Envision Healthcare Corporation (NYSE:EVHC) had its price objective reduced by KeyCorp from $67.00 to $37.00 in a report published on Thursday, November 2nd. They currently have an overweight rating on the stock.
Several other research analysts also recently commented on EVHC. Cantor Fitzgerald reaffirmed a buy rating on shares of Envision Healthcare Corporation in a research report on Monday, July 24th. Zacks Investment Research downgraded Envision Healthcare Corporation from a buy rating to a hold rating in a research report on Friday, July 7th. BidaskClub downgraded Envision Healthcare Corporation from a hold rating to a sell rating in a research report on Tuesday, August 1st. Mizuho dropped their price target on Envision Healthcare Corporation from $65.00 to $57.00 and set a neutral rating on the stock in a research report on Wednesday, August 9th. Finally, Jefferies Group LLC set a $71.00 price target on Envision Healthcare Corporation and gave the stock a buy rating in a research report on Thursday, August 24th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of Buy and an average target price of $49.43.
Shares of Envision Healthcare Corporation (NYSE EVHC) traded up $2.66 during mid-day trading on Thursday, hitting $28.52. The company had a trading volume of 13,625,400 shares, compared to its average volume of 2,162,887. The company has a debt-to-equity ratio of 0.89, a current ratio of 3.01 and a quick ratio of 3.00. Envision Healthcare Corporation has a 1-year low of $23.77 and a 1-year high of $74.75. The company has a market cap of $3,450.00, a P/E ratio of 7.98, a price-to-earnings-growth ratio of 0.67 and a beta of 0.69.
Envision Healthcare Corporation (NYSE:EVHC) last issued its quarterly earnings data on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.81 by ($0.08). Envision Healthcare Corporation had a negative net margin of 6.39% and a positive return on equity of 4.88%. The company had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $2.03 billion. During the same period in the previous year, the business posted $1.13 earnings per share. The firm’s revenue was up 142.0% on a year-over-year basis. sell-side analysts predict that Envision Healthcare Corporation will post 2.56 earnings per share for the current fiscal year.
Envision Healthcare Corporation declared that its board has approved a share repurchase program on Monday, September 18th that allows the company to repurchase $250.00 million in outstanding shares. This repurchase authorization allows the company to buy up to 4.5% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s board believes its shares are undervalued.
A number of institutional investors have recently bought and sold shares of EVHC. Teachers Advisors LLC boosted its stake in Envision Healthcare Corporation by 1.0% in the first quarter. Teachers Advisors LLC now owns 329,462 shares of the company’s stock worth $20,203,000 after purchasing an additional 3,230 shares in the last quarter. Paloma Partners Management Co boosted its stake in Envision Healthcare Corporation by 37.6% in the first quarter. Paloma Partners Management Co now owns 8,514 shares of the company’s stock worth $522,000 after purchasing an additional 2,328 shares in the last quarter. HighTower Advisors LLC boosted its stake in Envision Healthcare Corporation by 5.6% in the first quarter. HighTower Advisors LLC now owns 4,541 shares of the company’s stock worth $274,000 after purchasing an additional 240 shares in the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new position in Envision Healthcare Corporation in the first quarter worth $952,000. Finally, Xact Kapitalforvaltning AB boosted its stake in Envision Healthcare Corporation by 1.8% in the second quarter. Xact Kapitalforvaltning AB now owns 14,627 shares of the company’s stock worth $917,000 after purchasing an additional 258 shares in the last quarter.
About Envision Healthcare Corporation
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with our FREE daily email newsletter.